Frontierby eninvs

Language: EN · RU

← Region

Ozon Pharm RUB

Update

Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.

Sector: Healthcare

RU_OZPH

Price chart

46.07 RUBDay -0.22%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
46.07 RUB · -0.22%
Market cap
53.8 bn RUB

Growth

Δ revenue y/y
15.4%
Δ EBITDA y/y
16.4%

Multiples

P/E (LTM)
8.7x
3y avg: 10.1x
P/B (FY)
1.6x
P/E (ann.)
4.9x
EV/EBITDA (LTM)
5.3x
3y avg: 6.1x
EV/EBITDA (ann.)
3.7x

Cash return

Dividend yield
2.3%
FCF yield (LTM)
1.6%

Liquidity

Daily turnover (MOEX)
85.5 mln RUB

Shares: connector/market_inputs

Amounts: USD (converted) · As reported
Converted modes use NBK / ECB-linked rates: balance sheet date for BS items, period average for P&L and cash flow (see filing row evidence). As reported keeps each row in its filing currency.

🔍 Sanity check — subtotal consistency (Level-1 + Level-2) OK: 8 / Warn: 5 / Err: 4 / Autofix applied: 0
Port of PHP subtotal-total + sign-flip detection logic
PeriodIssues
2023-06-30 Q2OK
2023-09-30 9MOK
2023-09-30 Q3Warn 1
2023-12-31 FYOK
2023-12-31 Q4Errors 1
2024-03-31 Q1Errors 1Warn 2
2024-06-30 Q2Warn 1
2024-09-30 9MWarn 2
2024-09-30 Q3Errors 1Warn 2
2024-12-31 FYOK
2024-12-31 Q4Warn 1
2025-03-31 Q1OK
2025-06-30 Q2Errors 1Warn 2
2025-09-30 9MOK
2025-09-30 Q3OK
2025-12-31 FYOK
2025-12-31 Q4Warn 2
All checks pass · Has warnings (review) · Has errors (needs fix) · ✓* Autofix applied (see evidence)

Financial dynamics

Monetary columns are in B RUB, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB RUBOperating profitB RUBD&AB RUBEBITDAB RUBNet profitB RUBOperating CFB RUBCapex + M&AB RUBAssetsB RUBEquityB RUBROE (annualized)Net debtB RUBSource
2025-12-31FY 2025 (12M)OK10.2
y/y 15.4%
4.0
y/y 16.8%
0.3
y/y 6.8%
4.3
y/y 16.0%
2.7
y/y 17.9%
-0.153.2
y/y 7.5%
33.2
y/y 31.0%
19.3%9.3
2025-09-30Q3 2025 (3M)PARTIAL8.2
y/y 52.7%
2.9
y/y 138.3%
0.3
y/y 0.0%
3.2
y/y 110.0%
1.7
y/y 356.3%
0.551.3
y/y 25.8%
30.7
y/y 33.7%
7.7%17.2
2025-06-30Q2 2025 (3M)OK6.4
y/y -4.2%
1.7
y/y -15.1%
0.3
y/y 19.8%
2.1
y/y -11.1%
0.7
y/y -37.2%
2.3-2.450.3
y/y 31.0%
29.1
y/y 30.0%
10.4%7.3
2025-03-31Q1 2025 (3M)PARTIAL6.9
y/y 45.2%
2.2
y/y 70.0%
0.3
y/y 0.0%
2.5
y/y 58.4%
1.0
y/y 28.0%
0.449.6
y/y
26.3
y/y
15.4%19.0
2024-12-31FY 2024 (12M)OK8.8
y/y
3.4
y/y
0.3
y/y
3.7
y/y
2.3
y/y
-0.4-1.349.5
y/y 45.2%
25.3
y/y 48.0%
19.1%10.2
2024-09-30Q3 2024 (3M)OK5.3
y/y -8.5%
1.2
y/y -53.1%
0.3
y/y 1404.3%
1.5
y/y -41.5%
0.4
y/y -80.4%
-0.8-1.340.8
y/y
22.9
y/y
2.2%10.1
2024-06-30Q2 2024 (3M)OK6.7
y/y 73.1%
2.0
y/y 186.5%
0.3
y/y 19.4%
2.3
y/y 146.6%
1.1
y/y 253.1%
4.7-0.738.4
y/y
22.4
y/y
8.2
2024-03-31Q1 2024 (3M)PARTIAL4.7
y/y
1.3
y/y
0.3
y/y
1.6
y/y
0.8
y/y
2.3-0.7
y/y
y/y
10.0
2023-12-31FY 2023 (12M)OK
y/y
y/y
y/y
y/y
y/y
34.1
y/y
17.1
y/y
13.5
2023-09-30Q3 2023 (3M)PARTIAL5.8
y/y
2.6
y/y
0.0
y/y
2.6
y/y
1.9
y/y
1.6-0.3
y/y
y/y
9.1
2023-06-30Q2 2023 (3M)PARTIAL3.9
y/y
0.7
y/y
0.2
y/y
0.9
y/y
0.3
y/y
2.1-0.4
y/y
y/y
9.5
Data quality — review suggested

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

-5 00005 00010 00015 0002023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Year-over-year change

-200%-100%0%100%2023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Cash flow

Net debt / cash ($ mln)

05 00010 00015 00020 0002023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Fundamental value creation

Value the company creates per year, as a % of market cap

Value created per year: +20.1%

How this was calculated
1. EBITDA growth (latest quarter YoY, annualised)
[EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2025-12-31 vs 2024-12-31)
= (4 272 − 3 672) × 2.81
1 686
2. Current EV/EBITDA (LTM)
(Market cap + Net debt) ÷ EBITDA (LTM)
= (53 796 + 9 288) ÷ 11 994
5.3x
3. Target multiple
(Current EV/EBITDA + 6.5) ÷ 2
= (5.3 + 6.5) ÷ 2
5.9x
4. Cash flow (balance method, LTM)
Net-debt reduction + dividends + buybacks − equity issuance
= 879 + 0 + 0 − 0
879
5. Value created per year
(EBITDA growth × Target multiple + Cash flow) ÷ Market cap
= (1 686 × 5.9 + 879) ÷ 53 796
+20.1%

Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.

Caveats:

Dividends

No dividend rows found for this issuer.

Reporting forms detected in loaded periods: (Balance sheet / Profit or loss (P&L) / Cash flows)